Abstract
Contrast agents themselves and their use in medical imaging evolve very rapidly. Applications such as perfusion imaging make contrast agents critical elements of medical imaging. Tissue-specific contrast agents such as hepatocyte-specific MR contrast agent Gd-EOB-DTPA are smart molecules and will become commonplace in the near future. Artificial intelligence will make it possible to collect more detailed and sophisticated data using reduced amounts of contrast agents.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lohrke J, Frenzel T, Endrikat J, et al. 25 years of contrast-enhanced MRI: developments, current challenges and future perspectives. Adv Ther. 2016;33(1):1–28.
Covington MF, Pizzitola VJ, Lorans R, et al. The future of contrast-enhanced mammography. Am J Roentgenol. 2018;210(2):292–300.
Faggioni L, Gabelloni M. Iodine concentration and optimization in computed tomography angiography: current issues. Invest Radiol. 2016;51(12):816–22.
Kekelidze M, Dwarkasing RS, Dijkshoorn ML, et al. Kidney and urinary tract imaging: triple-bolus multidetector CT urography as a one-stop shop—protocol design, opacification, and image quality analysis. Radiology. 2010;255(2):508–16.
Young VE, Degnan AJ, Gillard JH. Advances in contrast media for vascular imaging of atherosclerosis. Imaging Med. 2011;3(3):353.
Ahn S, Jung SY, Lee SJ. Gold nanoparticle contrast agents in advanced X-ray imaging technologies. Molecules. 2013;18(5):5858–90.
Khairnar S, More N, Mounika C, Kapusetti G. Advances in contrast agents for contrast-enhanced magnetic resonance imaging. J Med Imaging Radiat Sci. 2019;50(4):575–89.
Koç MM, Aslan N, Kao AP, Barber AH. Evaluation of X-ray tomography contrast agents: a review of production, protocols, and biological applications. Microsc Res Tech. 2019;82(6):812–48.
Stride E, Segers T, Lajoinie G, et al. Microbubble agents: new directions. Ultrasound Med Biol. 2020;46(6):1326–43.
Caschera L, Lazzara A, Piergallini L, et al. Contrast agents in diagnostic imaging: present and future. Pharmacol Res. 2016;110:65–75.
Pedersoli F, Bruners P, Kuhl C, Schmitz-Rode T. Current CO2 angiography. Radiologe. 2019;59(6):533–40.
Gong E, Pauly JM, Wintermark M, Zaharchuk G. Deep learning enables reduced gadolinium dose for contrast-enhanced brain MRI. J Magn Reson Imaging. 2018;48(2):330–40.
Liu F, Jang H, Kijowski R, Bradshaw T, McMillan AB. Deep learning MR imaging–based attenuation correction for PET/MR imaging. Radiology. 2017;286(2):676–84.
Nakao T, Hanaoka S, Nomura Y, et al. Deep neural network-based computer-assisted detection of cerebral aneurysms in MR angiography. J Magn Reson Imaging. 2018;47(4):948–53.
Zaharchuk G, Gong E, Wintermark M, Rubin D, Langlotz C. Deep learning in neuroradiology. Am J Neuroradiol. 2018;39(10):1776–84.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ros, P.R., Inan, I., Erturk, S.M. (2021). Quo Vadis: An Epilog. In: Erturk, S.M., Ros, P.R., Ichikawa, T., Saylisoy, S. (eds) Medical Imaging Contrast Agents: A Clinical Manual. Springer, Cham. https://doi.org/10.1007/978-3-030-79256-5_25
Download citation
DOI: https://doi.org/10.1007/978-3-030-79256-5_25
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-79255-8
Online ISBN: 978-3-030-79256-5
eBook Packages: MedicineMedicine (R0)